+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

in Vitro Diagnostics (IVD) Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents), Test Location, End-use (Hospitals, Laboratory), Application (Diabetes, Oncology), Technology, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 200 Pages
  • January 2024
  • Region: Global
  • Grand View Research
  • ID: 4582041
Description Jump to:
The global in vitro diagnostics market is expected to reach USD 101.58 billion by 2030. It is estimated to register a CAGR of 4.4% over the forecast period driven by the increasing geriatric population, COVID-19 pandemic, and technological advancements in diagnostics that are supporting its adoption. Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be one of the high-impact rendering drivers. Technological advancements were further accelerated by the launch of COVID-19 IVD diagnostics and enhanced the adoption of instruments and consumables for technologies, such as PCR. Competitors in the market are increasingly adopting agreement and partnership strategies to maintain a constant flow of business for manufacturers & diagnostics for users.

These agreements are also a result of the harsh price containment strategies for government laboratories, which lowers the price in government settings. For instance, in April 2021, the Italian subsidiary of Seegene, Inc. received a USD 108.25 million tenders for public procurement for the supply of extraction reagents, as well as 7.15 million SARS-CoV-2 diagnostic tests. However, it increases the multiparty nature and complexity of the supply chain. The high prevalence of cancer and Cardiovascular Diseases (CVDs) globally is anticipated to drive diagnostic innovation to facilitate early diagnosis and meet the constantly evolving needs of consumers. Novel technologies, such as plasmonic PCR, are anticipated to commercially enter the market during the forecast period, influencing the business of existing products adversely.

In Vitro Diagnostics Market Report Highlights

  • Molecular diagnostics is anticipated to grow at the fastest CAGR from 2024 to 2030 owing to the rising adoption and usage rate
  • Reagents held the largest market share owing to the surge in demand for genetic testing and enhanced availability of technologically advanced diagnostic tests in lower and middle-income countries with unmet clinical needs
  • The infectious diseases application segment held the largest market share owing to the large volume of testing for infectious diseases globally
  • North America dominated the global market in 2023 owing to the high demand for novel technologies, a large pool of key players, high prevalence of diseases, and advanced healthcare infrastructure

Table of Contents

Chapter 1 In Vitro Diagnostics Market: Methodology and Scope
1.1 Market Segmentation
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1
1.11.2 Objective 2
1.12 List Of Abbreviations
Chapter 2 In Vitro Diagnostics Market: Market Definitions
Chapter 3 In Vitro Diagnostics Market: Executive Summary
3.1 Market Summary
Chapter 4. In Vitro Diagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. In Vitro Diagnostics Market: Product Movement Analysis, USD Million, 2023 & 2030 (Volume Analysis)
4.3. Instruments
4.3.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold)
4.4. Reagents
4.4.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Tests Sold)
4.5. Services
4.5.1. Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. In Vitro Diagnostics Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. In Vitro Diagnostics Market: Technology Movement Analysis, USD Million, 2023 & 2030 (Volume Analysis)
5.3. Immunoassay
5.3.1. Immunoassay Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3.2. Instruments
5.3.2.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3.3. Reagents
5.3.3.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3.4. Services
5.3.4.1. Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.4. Hematology
5.4.1. Hematology Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.4.2. Instruments
5.4.2.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.4.3. Reagents
5.4.3.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.4.4. Services
5.4.4.1. Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.5. Clinical Chemistry
5.5.1. Clinical Chemistry Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.5.2. Instruments
5.5.2.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.5.3. Reagents
5.5.3.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.5.4. Services
5.5.4.1. Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Molecular Diagnostics
5.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.6.2. Instruments
5.6.2.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.6.3. Reagents
5.6.3.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.6.4. Services
5.6.4.1. Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.7. Coagulation
5.7.1. Coagulation Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.7.2. Instruments
5.7.2.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.7.3. Reagents
5.7.3.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.7.4. Services
5.7.4.1. Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.8. Microbiology
5.8.1. Microbiology Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.8.2. Instruments
5.8.2.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.8.3. Reagents
5.8.3.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.8.4. Services
5.8.4.1. Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.9. Others
5.9.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.9.2. Instruments
5.9.2.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.9.3. Reagents
5.9.3.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.9.4. Services
5.9.4.1. Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. In Vitro Diagnostics Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. In Vitro Diagnostics Market: Application Movement Analysis, USD Million, 2023 & 2030
6.3. Infectious Disease
6.3.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.4. Diabetes
6.4.1. Diabetes Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Oncology/Cancer
6.5.1. Oncology/Cancer Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.6. Cardiology
6.6.1. Cardiology Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.7. Nephrology
6.7.1. Nephrology Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.8. Autoimmune Diseases
6.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.9. Drug Testing
6.9.1. Drug Testing Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.10. Others
6.10.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. In Vitro Diagnostics Market: Test Location Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. In Vitro Diagnostics Market: Test Location Movement Analysis, USD Million, 2023 & 2030
7.3. Point of Care
7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
7.4. Home-care
7.4.1. Home-care Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
7.5. Others
7.5.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 8. In Vitro Diagnostics Market: End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. In Vitro Diagnostics Market: End Use Movement Analysis, USD Million, 2023 & 2030
8.3. Hospitals
8.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
8.4. Laboratory
8.4.1. Laboratory Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
8.5. Home-care
8.5.1. Home-care Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
8.6. Others
8.6.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 9. In Vitro Diagnostics Market: Regional Estimates & Trend Analysis
9.1. In Vitro Diagnostics Market Share, by Region, 2023 & 2030, USD Million
9.2. North America
9.2.1. North America In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.2.2. U.S.
9.2.2.1. Key Country Dynamics
9.2.2.2. Regulatory Landscape/Reimbursement Scenario
9.2.2.3. Competitive Insights
9.2.2.4. U.S. In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.2.3. Canada
9.2.3.1. Key Country Dynamics
9.2.3.2. Regulatory Landscape/Reimbursement Scenario
9.2.3.3. Competitive Insights
9.2.3.4. Canada In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.3. Europe
9.3.1. Europe In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.3.2. UK
9.3.2.1. Key Country Dynamics
9.3.2.2. Regulatory Landscape/Reimbursement Scenario
9.3.2.3. Competitive Insights
9.3.2.4. U.K. In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.3. Germany
9.3.3.1. Key Country Dynamics
9.3.3.2. Regulatory Landscape/Reimbursement Scenario
9.3.3.3. Competitive Insights
9.3.3.4. Germany In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.3.4. France
9.3.4.1. Key Country Dynamics
9.3.4.2. Regulatory Landscape/Reimbursement Scenario
9.3.4.3. Competitive Insights
9.3.4.4. France In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.3.5. Italy
9.3.5.1. Key Country Dynamics
9.3.5.2. Regulatory Landscape/Reimbursement Scenario
9.3.5.3. Competitive Insights
9.3.5.4. Italy In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.3.6. Spain
9.3.6.1. Key Country Dynamics
9.3.6.2. Regulatory Landscape/Reimbursement Scenario
9.3.6.3. Competitive Insights
9.3.6.4. Spain In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.3.7. Sweden
9.3.7.1. Key Country Dynamics
9.3.7.2. Regulatory Landscape/Reimbursement Scenario
9.3.7.3. Competitive Insights
9.3.7.4. Sweden In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.3.8. Denmark
9.3.8.1. Key Country Dynamics
9.3.8.2. Regulatory Landscape/Reimbursement Scenario
9.3.8.3. Competitive Insights
9.3.8.4. Denmark In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.3.9. Norway
9.3.9.1. Key Country Dynamics
9.3.9.2. Regulatory Landscape/Reimbursement Scenario
9.3.9.3. Competitive Insights
9.3.9.4. Norway In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.3.10. Russia
9.3.10.1. Key Country Dynamics
9.3.10.2. Regulatory Landscape/Reimbursement Scenario
9.3.10.3. Competitive Insights
9.3.10.4. Russis In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.4. Asia-Pacific
9.4.1. Asia-Pacific In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.4.2. China
9.4.2.1. Key Country Dynamics
9.4.2.2. Regulatory Landscape/Reimbursement Scenario
9.4.2.3. Competitive Insights
9.4.2.4. China In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.4.3. Japan
9.4.3.1. Key Country Dynamics
9.4.3.2. Regulatory Landscape/Reimbursement Scenario
9.4.3.3. Competitive Insights
9.4.3.4. Japan In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.4.4. India
9.4.4.1. Key Country Dynamics
9.4.4.2. Regulatory Landscape/Reimbursement Scenario
9.4.4.3. Competitive Insights
9.4.4.4. India In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.4.5. South Korea
9.4.5.1. Key Country Dynamics
9.4.5.2. Regulatory Landscape/Reimbursement Scenario
9.4.5.3. Competitive Insights
9.4.5.4. South Korea In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.4.6. Australia
9.4.6.1. Key Country Dynamics
9.4.6.2. Regulatory Landscape/Reimbursement Scenario
9.4.6.3. Competitive Insights
9.4.6.4. Australia In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.4.7. Thailand
9.4.7.1. Key Country Dynamics
9.4.7.2. Regulatory Landscape/Reimbursement Scenario
9.4.7.3. Competitive Insights
9.4.7.4. Thailand In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.4.8. Singapore
9.4.8.1. Key Country Dynamics
9.4.8.2. Regulatory Landscape/Reimbursement Scenario
9.4.8.3. Competitive Insights
9.4.8.4. Singapore In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.5. Latin America
9.5.1. Latin America In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.5.2. Brazil
9.5.2.1. Key Country Dynamics
9.5.2.2. Regulatory Landscape/Reimbursement Scenario
9.5.2.3. Competitive Insights
9.5.2.4. Brazil In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.5.3. Mexico
9.5.3.1. Key Country Dynamics
9.5.3.2. Regulatory Landscape/Reimbursement Scenario
9.5.3.3. Competitive Insights
9.5.3.4. Mexico In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.5.4. Argentina
9.5.4.1. Key Country Dynamics
9.5.4.2. Regulatory Landscape/Reimbursement Scenario
9.5.4.3. Competitive Insights
9.5.4.4. Argentina In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.6. Middle East and Africa
9.6.1. Middle East and Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
9.6.2. Saudi Arabia
9.6.2.1. Key Country Dynamics
9.6.2.2. Regulatory Landscape/Reimbursement Scenario
9.6.2.3. Competitive Insights
9.6.2.4. Saudi Arabia In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.6.3. UAE
9.6.3.1. Key Country Dynamics
9.6.3.2. Regulatory Landscape/Reimbursement Scenario
9.6.3.3. Competitive Insights
9.6.3.4. UAE In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.6.4. South Africa
9.6.4.1. Key Country Dynamics
9.6.4.2. Regulatory Landscape/Reimbursement Scenario
9.6.4.3. Competitive Insights
9.6.4.4. South Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.6.5. Kuwait
9.6.5.1. Key Country Dynamics
9.6.5.2. Regulatory Landscape/Reimbursement Scenario
9.6.5.3. Competitive Insights
9.6.5.4. Kuwait In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis by Key Market Participants
10.2. Company Categorization
10.3. Global Company Market Share Analysis, 2023
10.4. Company Heat Map Analysis
10.5. Strategy Mapping
10.5.1. Expansion
10.5.2. Mergers & Acquisition
10.5.3. Partnerships & Collaborations
10.5.4. New Product Launches
10.5.5. Research And Development
10.6. Company Profiles
10.6.1. QIAGEN
10.6.1.1. Participant’s Overview
10.6.1.2. Financial Performance
10.6.1.3. Product Benchmarking
10.6.1.4. Recent Developments
10.6.2. BD
10.6.2.1. Participant’s Overview
10.6.2.2. Financial Performance
10.6.2.3. Product Benchmarking
10.6.2.4. Recent Developments
10.6.3. bioMérieux SA
10.6.3.1. Participant’s Overview
10.6.3.2. Financial Performance
10.6.3.3. Product Benchmarking
10.6.3.4. Recent Developments
10.6.4. F. Hoffmann-La Roche, Ltd.
10.6.4.1. Participant’s Overview
10.6.4.2. Financial Performance
10.6.4.3. Product Benchmarking
10.6.4.4. Recent Developments
10.6.5. QuidelOrtho Corporation
10.6.5.1. Participant’s Overview
10.6.5.2. Financial Performance
10.6.5.3. Product Benchmarking
10.6.5.4. Recent Developments
10.6.6. Abbott
10.6.6.1. Participant’s Overview
10.6.6.2. Financial Performance
10.6.6.3. Product Benchmarking
10.6.6.4. Recent Developments
10.6.7. Agilent Technologies, Inc.
10.6.7.1. Participant’s Overview
10.6.7.2. Financial Performance
10.6.7.3. Product Benchmarking
10.6.7.4. Recent Developments
10.6.8. Siemens Healthineers AG
10.6.8.1. Participant’s Overview
10.6.8.2. Financial Performance
10.6.8.3. Product Benchmarking
10.6.8.4. Recent Developments
10.6.9. Bio-Rad Laboratories, Inc.
10.6.9.1. Participant’s Overview
10.6.9.2. Financial Performance
10.6.9.3. Product Benchmarking
10.6.9.4. Recent Developments
10.6.10. Danaher
10.6.10.1. Participant’s Overview
10.6.10.2. Financial Performance
10.6.10.3. Product Benchmarking
10.6.10.4. Recent Developments
10.6.11. Sysmex Corporation
10.6.11.1. Participant’s Overview
10.6.11.2. Financial Performance
10.6.11.3. Product Benchmarking
10.6.11.4. Recent Developments
10.6.12. Charles River Laboratories
10.6.12.1. Participant’s Overview
10.6.12.2. Financial Performance
10.6.12.3. Product Benchmarking
10.6.12.4. Recent Developments
10.6.13. Quest Diagnostics Incorporated
10.6.13.1. Participant’s Overview
10.6.13.2. Financial Performance
10.6.13.3. Product Benchmarking
10.6.13.4. Recent Developments
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Regulatory Framework
Table 4 Global In Vitro Diagnostics Market, By Region, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million Number of instruments installed in thousands, Number of reagents sold in million
Table 5 Global In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 6 Global In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 7 Global In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 8 Global In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 9 Global In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 10 North America In Vitro Diagnostics Market, By Country, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 11 North America In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 12 North America In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 13 North America In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 14 North America In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 15 North America In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 16 U.S. In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 17 U.S. In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 18 U.S. In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 19 U.S. In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 20 U.S. In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 21 Canada In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 22 Canada In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 23 Canada In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 24 Canada In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 25 Canada In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 26 Europe In Vitro Diagnostics Market, By Country, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 27 Europe In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 28 Europe In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 29 Europe In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 30 Europe In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 31 Europe In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 32 UK In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 33 UK In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 34 UK In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 35 UK In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 36 UK In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 37 Germany In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 38 Germany In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 39 Germany In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 40 Germany America In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 41 Germany In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 42 France In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 43 France In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 44 France In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 45 France In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 46 France In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 47 Spain In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 48 Spain In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 49 Spain In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 50 Spain In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 51 Spain In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 52 Italy In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 53 Italy In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 54 Italy In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 55 Italy In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 56 Italy In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 57 Russia In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 58 Russia In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 59 Russia In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 60 Russia In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 61 Russia In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 62 Asia-Pacific In Vitro Diagnostics Market, By Country, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 63 Asia-Pacific In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 64 Asia-Pacific In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 65 Asia-Pacific In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 66 Asia-Pacific In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 67 Asia-Pacific In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 68 China In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 69 China In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 70 China In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 71 China In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 72 China In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 73 Japan In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 74 Japan In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 75 Japan In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 76 Japan In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 77 Japan In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 78 India In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 79 India In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 80 India In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 81 India In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 82 India In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 83 South Korea In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 84 South Korea In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 85 South Korea In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 86 South Korea In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 87 South Korea In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 88 Singapore In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 89 Singapore In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 90 Singapore In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 91 Singapore In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 92 Singapore In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 93 Australia In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 94 Australia In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 95 Australia In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 96 Australia In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 97 Australia In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 98 Latin America In Vitro Diagnostics Market, By Country, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 99 Latin America In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 100 Latin America In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 101 Latin America In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 102 Latin America In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 103 Latin America In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 104 Brazil In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 105 Brazil In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 106 Brazil In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 107 Brazil In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 108 Brazil In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 109 Mexico In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 110 Mexico In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 111 Mexico In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 112 Mexico In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 113 Mexico In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 114 Argentina In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 115 Argentina In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 116 Argentina In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 117 Argentina In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 118 Argentina In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 119 MEA In Vitro Diagnostics Market, By Country, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 120 MEA In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 121 MEA In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 122 MEA In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 123 MEA In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 124 MEA In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 125 South Africa In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 126 South Africa In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 127 South Africa In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 128 South Africa In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 129 UAE In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 130 UAE In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 131 UAE In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 132 UAE In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 133 UAE In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 134 UAE In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
Table 135 Saudi Arabia In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 136 Saudi Arabia In Vitro Diagnostics Market, By Technology, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 137 Saudi Arabia In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 138 Saudi Arabia In Vitro Diagnostics Market, By End-use, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
Table 139 Saudi Arabia In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
List of Figures
Fig. 1 In Vitro Diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 In vitro diagnostic market snapshot
Fig. 10 Parent market outlook, 2023
Fig. 11 Penetration and growth prospect mapping
Fig. 12 In vitro diagnostic market driver impact
Fig. 13 Global population by age group, 2016 & 2027
Fig. 14 Global elderly population
Fig. 15 New cancer cases by year
Fig. 16 In vitro diagnostic market restraint impact
Fig. 17 Market entry strategy
Fig. 18 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 19 Porter’s five forces analysis
Fig. 20 Consumer behavior analysis
Fig. 21 Strategy mapping
Fig. 22 IVD market: Product outlook and key takeaways
Fig. 23 IVD market: Products movement analysis
Fig. 24 Instruments market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands
Fig. 25 Reagents market estimates and forecast, 2018-2030 (USD Million), Number of reagents sold in millions
Fig. 26 Services market estimates and forecast, 2018-2030 (USD Million)
Fig. 27 IVD market: Technology outlook and key takeaways
Fig. 28 IVD Market: Technology movement analysis
Fig. 29 Immunoassay market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 30 Instruments market for immunoassay estimates and forecast, 2018-2030 (USD Million)
Fig. 31 Reagents market for immunoassay estimates and forecast, 2018-2030 (USD Million)
Fig. 32 Services market for immunoassay estimates and forecast, 2018-2030 (USD Million)
Fig. 33 Hematology market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 34 Instruments market for hematology estimates and forecast, 2018-2030 (USD Million)
Fig. 35 Reagents market for hematology estimates and forecast, 2018-2030 (USD Million)
Fig. 36 Services market for hematology estimates and forecast, 2018-2030 (USD Million)
Fig. 37 Clinical chemistry market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 38 Instruments market for clinical chemistry estimates and forecast, 2018-2030 (USD Million)
Fig. 39 Reagents market for clinical chemistry estimates and forecast, 2018-2030 (USD Million)
Fig. 40 Services market for clinical chemistry estimates and forecast, 2018-2030 (USD Million)
Fig. 41 Molecular diagnostics market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 42 Instruments market for molecular diagnostics estimates and forecast, 2018-2030 (USD Million)
Fig. 43 Reagents market for molecular diagnostics estimates and forecast, 2018-2030 (USD Million)
Fig. 44 Services market for molecular diagnostics estimates and forecast, 2018-2030 (USD Million)
Fig. 45 Coagulation market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 46 Instruments market for coagulation estimates and forecast, 2018-2030 (USD Million)
Fig. 47 Reagents market for coagulation estimates and forecast, 2018-2030 (USD Million)
Fig. 48 Services market for coagulation estimates and forecast, 2018-2030 (USD Million)
Fig. 49 Microbiology market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 50 Instruments market for microbiology estimates and forecast, 2018-2030 (USD Million)
Fig. 51 Reagents market for microbiology estimates and forecast, 2018-2030 (USD Million)
Fig. 52 Services market for microbiology estimates and forecast, 2018-2030 (USD Million)
Fig. 53 Others market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 54 Instruments others market estimates and forecast, 2018-2030 (USD Million)
Fig. 55 Reagents others market estimates and forecast, 2018-2030 (USD Million)
Fig. 56 Services market for other technology estimates and forecast, 2018-2030 (USD Million)
Fig. 57 IVD market: Application outlook and key takeaways
Fig. 58 IVD market: Application movement analysis
Fig. 59 Infectious diseases market estimates and forecast, 2018-2030 (USD Million)
Fig. 60 Diabetes market estimates and forecast, 2018-2030 (USD Million)
Fig. 61 Oncology market estimates and forecast, 2018-2030 (USD Million)
Fig. 62 Cardiology market estimates and forecast, 2018-2030 (USD Million)
Fig. 63 Nephrology market estimates and forecast, 2018-2030 (USD Million)
Fig. 64 Autoimmune diseases market estimates and forecast, 2018-2030 (USD Million)
Fig. 65 Drug testing market estimates and forecast, 2018-2030 (USD Million)
Fig. 66 Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 67 IVD market: End-use outlook and key takeaways
Fig. 68 IVD treatment market: End-use movement analysis
Fig. 69 Hospitals market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 70 Laboratory market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 71 Home care market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 72 Other market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 73 IVD market: test location outlook and key takeaways
Fig. 74 IVD treatment market: Test location movement analysis
Fig. 75 Point-of-care market estimates and forecast, 2018-2030 (USD Million)
Fig. 76 Homecare market estimates and forecast, 2018-2030 (USD Million)
Fig. 77 Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 78 IVD Market: Regional outlook and key takeaways
Fig. 79 IVD market: Regional movement analysis
Fig. 80 North America
Fig. 81 North America, SWOT
Fig. 82 North America. market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 83 U.S. key country dynamics
Fig. 84 U.S. market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 85 Canada key country dynamics
Fig. 86 Canada market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 87 Europe
Fig. 88 Europe, SWOT
Fig. 89 Europe market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 90 UK key country dynamics
Fig. 91 UK market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 92 Germany key country dynamics
Fig. 93 Germany market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 94 Spain key country dynamics
Fig. 95 Spain market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 96 France key country dynamics
Fig. 97 France market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 98 Italy key country dynamics
Fig. 99 Italy market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 100 Russia key country dynamics
Fig. 101 Russia market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 102 Denmark key country dynamics
Fig. 103 Denmark market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 104 Sweden key country dynamics
Fig. 105 Sweden market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 106 Norway key country dynamics
Fig. 107 Norway market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 108 Asia-Pacific
Fig. 109 Asia-Pacific, SWOT
Fig. 110 Asia-Pacific market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 111 Japan key country dynamics
Fig. 112 Japan market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 113 China key country dynamics
Fig. 114 China. market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 115 India key country dynamics
Fig. 116 India. market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 117 South Korea key country dynamics
Fig. 118 South Korea market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 119 Singapore key country dynamics
Fig. 120 Singapore market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 121 Thailand key country dynamics
Fig. 122 Thailand market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 123 Australia key country dynamics
Fig. 124 Australia market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 125 Latin America
Fig. 126 Latin America, SWOT
Fig. 127 Latin America market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 128 Brazil key country dynamics
Fig. 129 Brazil market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 130 Mexico key country dynamics
Fig. 131 Mexico market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 132 Argentina key country dynamics
Fig. 133 Argentina market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 134 Middle East & Africa
Fig. 135 Middle East & Africa, SWOT
Fig. 136 MEA market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 137 South Africa key country dynamics
Fig. 138 South Africa market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 139 United Arab Emirates key country dynamics
Fig. 140 United Arab Emirates market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 141 Saudi Arabia key country dynamics
Fig. 142 Saudi Arabia market estimates and forecast, 2018-2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
Fig. 143 Ansoff matrix
Fig. 144 Competition categorization
Fig. 145 Company market share analysis, 2023
Fig. 146 Global mass spectrometry company market share analysis, 2023
Fig. 147 North America mass spectrometry company market share analysis, 2023
Fig. 148 Europe mass spectrometry company market share analysis, 2023
Fig. 149 Asia-Pacific mass spectrometry company market share analysis, 2023
Fig. 150 Global immunoassay company market share analysis, 2023
Fig. 151 North America immunoassay company market share analysis, 2023
Fig. 152 Europe immunoassay company market share analysis, 2023
Fig. 153 Asia-Pacific immunoassay company market share analysis, 2023
Fig. 154 Global PCR company market share analysis, 2023
Fig. 155 North America PCR company market share analysis, 2023
Fig. 156 Europe PCR company market share analysis, 2023
Fig. 157 Asia-Pacific PCR company market share analysis, 2023
Fig. 158 Company market position analysis
Fig. 159 Company market position analysis
Fig. 160 Company market position analysis
Fig. 161 Company profiles
Fig. 162 Regional network map

Companies Mentioned

  • QIAGEN
  • BD
  • bioMérieux SA
  • F. Hoffmann-La Roche, Ltd.
  • QuidelOrtho Corporation
  • Abbott
  • Agilent Technologies, Inc.
  • Siemens Healthineers AG
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • Sysmex Corporation
  • Charles River Laboratories
  • Quest Diagnostics Incorporated

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages200
PublishedJanuary 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 77.92 Billion
Forecasted Market Value ( USD ) by 2030 $ 101.58 Billion
Compound Annual Growth Rate4.4%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

In Vitro Diagnostics Market, Industry Trends and Global Forecasts to 2035: Distribution by Test Type, Type of Offering, Type of Technology, Therapeutic Area, End Users and Geographical Regions - Product Image

In Vitro Diagnostics Market, Industry Trends and Global Forecasts to 2035: Distribution by Test Type, Type of Offering, Type of Technology, Therapeutic Area, End Users and Geographical Regions

  • Report
  • 188 Pages
  • Global
From
U.S. In-Vitro Diagnostics Market - Focused Insights 2024-2029 - Product Image

U.S. In-Vitro Diagnostics Market - Focused Insights 2024-2029

  • Report
  • 115 Pages
  • United States
From
North America In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis - by Product & Services, Technology, Application, and End User - Product Image

North America In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis - by Product & Services, Technology, Application, and End User

  • Report
  • 112 Pages
  • North America
From
In-Vitro Diagnostics Market by Component, Technology, Specimen, Application, End User - Global Forecast 2025-2030 - Product Image

In-Vitro Diagnostics Market by Component, Technology, Specimen, Application, End User - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Clinical Chemistry Analyzers Market Size, Share & Trends Analysis Report by Product (Analyzers, Reagents), Test (Basic Metabolic Panel, Electrolyte Panel), End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Clinical Chemistry Analyzers Market Size, Share & Trends Analysis Report by Product (Analyzers, Reagents), Test (Basic Metabolic Panel, Electrolyte Panel), End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.